Sensitive ASX Announcement

First Patient Recruited to ACCENT Trial in Pancreatic Cancer

Published: 02/08/22, 11:53am (AEST)2 pages
Amplia Therapeutics Limited
ATX:ASXHealthcare

Recent ATX Announcements

Price Sensitive only